Melatonin ameliorates the adverse effects of leptin on sperm by Almabhouh, Fayez et al.
Asian Journal of Andrology (2017) 19, 647–654 
www.asiaandro.com; www.ajandrology.com
species and also upregulates antioxidant enzymes and downregulates 
pro-oxidant enzymes. Therefore, diverse beneficial effects of melatonin 
have been claimed to protect against various degenerative conditions 
caused by oxidative stress. This study examined the effects of concurrent 
leptin treatment and melatonin supplementation on sperm count, 
sperm morphology, apoptosis, and DNA damage in normal adult rats.
MATERIALS AND METHODS
Experimental animals
Male Sprague-Dawley rats, aged 12 weeks, were obtained from the 
Laboratory Animal Care Unit (LACU), Universiti Teknologi MARA. 
Rats were housed in standard rat cages with commercial wood chip 
bedding at room temperature and with a 12/12 light/dark cycle. Rats 
had access ad libitum to commercial rat feed  (Specialty Feeds Pty 
Ltd., Perth, Australia) and tap water throughout the experimental 
period. The experimental protocol used in this study was approved by 
the Animal Care and Use Committee (ACUC), Universiti Teknologi 
MARA. Rats were randomized into five groups consisting of control, 
leptin, leptin-melatonin-10  (LM10), leptin-melatonin-20  (LM20), 
and melatonin-10  (M10) treated groups with 6 rats per group. All 
leptin-treated groups received intraperitoneal injections (i.p.) of leptin 
once daily for 42 days (60 µg kg−1 body weight; recombinant rat leptin, 
INTRODUCTION
Leptin, a 16-kDa protein that is produced and secreted mainly by 
the adipose tissue, is a hormone that has been shown to have roles in 
diverse physiological processes including regulation of body weight and 
food intake, immune function, hematopoiesis, inflammation, sexual 
maturation, and normal reproduction.1–4 However, a number of recent 
reports have indicated some adverse effects of leptin on sperm count 
and morphology. Exogenous leptin administration to normal rats for 
6 weeks was found to decrease sperm concentration while increasing 
the fraction of sperm with abnormal morphology.5–8 Although the 
precise mechanism for this remains unclear, leptin-induced oxidative 
stress has been implicated, as leptin administration has been shown 
to increase free radical production.8,9 Reactive oxygen species and 
their metabolites cause damage to the membrane lipids, DNA, and 
cellular proteins, and oxidative stress is now hypothesized as a possible 
cause of male infertility.10–13 While increased free radical production 
might be responsible for the leptin-induced decreases in sperm count 
and abnormal sperm morphology, it, however, remains unknown if 
concurrent antioxidant supplementation to leptin treated rats would 
prevent the adverse effects of leptin on some of these sperm parameters. 
Melatonin interacts with various reactive oxygen and reactive nitrogen 
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purity >95%, from BioVision Inc., Milpitas, California, USA). Rats in 
the leptin- and melatonin-treated groups, in addition to leptin, were 
given melatonin either 10  mg kg−1 or 20  mg kg−1 body weight per 
day (Sigma-Aldrich, St. Louis, MO, USA,) in drinking water for 42 days. 
Control rats received 0.1 ml of normal saline i.p. for 42 days. Body 
weights of control and experimental animals were monitored weekly. 
The duration and dose of leptin treatment were based on our previous 
studies in the rat where a more pronounced effect of leptin was evident 
following 42 days rather than after 7 days or 21 days of treatment.5,6 
Although the dose of leptin used in these studies ranged from 5 μg kg-1 
to 30 µg kg−1, to ensure a more pronounced effect, a dose of 60 µg kg−1 
body weight was used in this study. The study design and the use of 
animals were approved by the ACUC of Universiti Teknologi MARA.
Sperm collection
Upon completion of treatment, the animals were euthanized and the 
testes and epididymis were removed. The epididymis was minced in 
2 ml normal saline and then filtered through a nylon mesh to prepare 
an epididymal suspension for analysis.5 The left testis was immediately 
snap-frozen in liquid nitrogen and stored at −80°C for gene analysis at 
a later date. The right testis was immediately kept in 10% (v/v) buffered 
formalin for terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay.
Sperm count and morphology
The epididymal suspension was first mixed well and a small drop was 
placed in the center of the Makler chamber (Sefi Medical Instruments 
Ltd., Haifa, Israel) and covered with a glass cover. The droplet was 
allowed to spread on the entire area of the disc. The number of total and 
abnormal sperm in 10 squares was counted. This number represented 
the concentration of sperm in million per ml. This was repeated 
and the average of the two was determined and the concentration 
was expressed in million per ml. The number of abnormal sperm 
in the same 10 squares was recorded. The sperm was classified into 
normal and abnormal types.7 In brief, the sperm with the following 
characteristics was considered abnormal: (i) headless, (ii) hookless, (iii) 
cephalo-cauda (head pointing toward the tail), (iv) double-headed, (v) 
broken tail, (vi) microcephalic, (vii) coiled tail, and (viii) double-tailed.7
Quantitative measurement of 8‑hydroxy‑2‑deoxyguanosine (8‑OHdG)
Genomic DNA was isolated from the sperm sample of each animal 
using Genomic DNA Isolation Kit (BioVision Inc., Milpitas, California, 
USA). The DNA was hydrolyzed into nucleotides with 100 U ml−1 
nuclease P1 (Sigma-Aldrich, St. Louis, MO, USA) at 37°C for 60 min 
in 20 mmol l−1 sodium acetate buffer (pH 4.5).14 Then, 1 unit of alkaline 
phosphatase (Sigma-Aldrich, St. Louis, MO, USA) was added to 100 µg 
of DNA and incubated at 37°C for 30 min.14 The DNA lysate was boiled 
for 10 min, following which it was placed on ice at room temperature. 
8-OHdG EIA Kit (Cayman Chemical, Ann Arbor, MI, USA) was used 
to estimate 8-OHdG.
Sperm Comet assay
Comet assay was performed on sperm to assess its DNA integrity.15 
Frosted slides were covered with 100 µl of 1% (w/v) normal-melting 
agarose (NMA) with a cover slip and allowed to solidify at 4°C. After 
5 min, the cover slips were gently removed. Following this, 10 µl of the 
epididymal sperm sample from each rat containing 1 × 105 sperm was 
added to 90 µl of 1% (w/v) low-melting agarose (LMA), and 85 µl of 
the suspension from each rat was then gently pipetted onto the frosted 
slides with solidified NMA to form the second layer. Fresh cover slips 
were placed and the agarose was allowed to set at 4°C for 5–10 min. 
After this, the cover slips were removed and the slides were then placed 
in Coplin jars containing lysis buffer (2.5 mol l-1 NaCl, 100 mmol l-1 
Na2 EDTA, 10 mmol l-1 Tris base containing 1% (v/v) Triton X-100, 
and 40 mmol l-1 DL-dithiothreitol (Sigma-Aldrich St. Louis, MO, USA) 
and proteinase K 0.5 mg ml−1 (Affymetrix, Santa Clara, California, 
USA) at 37°C for 24 h. Following cell lysis, all slides were washed three 
times with deionized water for 10 min to remove salt and detergent 
from the gels. Slides were then coded and placed in a horizontal 
electrophoresis tank (Model Sub-Cell GT Basic, Bio-Rad, Hercules, 
CA, USA; max. volts 200 V, max. current 400 mA) filled with fresh 
alkaline electrophoresis buffer (300 mmol l-1 NaOH and 1 mmol l-1 
EDTA, pH 13) for 20 min to allow the DNA from the cells to unwind. 
Electrophoresis was performed at room temperature and conducted 
at 25 V, 300  mA for 20  min.16 The slides were then washed and 
neutralized with neutralization buffer (0.4 mol l-1 Tris-Base, pH 7.5) 
in 3 Coplin jars for 5 min each. After neutralization, slides were dried 
and stained with DNA SYBR Green 1 (Invitrogen-Molecular Probes, 
Foster, CA, USA; 1:10 000 dilution) for 30 min. The slides were then 
rinsed briefly with double-distilled water and cover slips were placed 
for image analysis. The fluorescent-labeled DNA was visualized (200×) 
using BX 61 Imager fluorescence microscope (Olympus Co., Tokyo, 
Japan) and the resulting images were captured on a computer. Comet 
Assay Software Project  (CASP) lab Version  1.2.3b1(Free Software 
Foundation Inc., Boston, MA, USA) was used to analyze the Comet 
images. Samples were run in duplicate and 100 cells were randomly 
analyzed per slide for a total of 200 cells per sample and scored for 
tail length (TL), tail moment (TM), olive tail moment (OTM), and 
% tail DNA.
TUNEL assay
Testicular tissues were fixed in 10% (v/v) buffered formalin, embedded 
in paraffin, and cut into thin sections with a microtome. TUNEL 
assay was used to study DNA fragmentation according to the 
manufacturer’s instructions (BioVision Inc., Milpitas, California, USA). 
TUNEL-positive cells were observed under fluorescent microscopy and 
images were acquired. The cells were quantified in each tissue section 
by counting the number of TUNEL-positive cells in the seminiferous 
tubule using Image Processing and Analysis Software (ImageJ 1.48v; 
NIH, Bethesda, Maryland, USA). Ten high-vision fields on each 
slide were examined and for each vision field, TUNEL-positive cells 
labeled in green were counted in a total of 100 cells. At least, a total of 
1000 cells were evaluated in each section and the apoptotic index (AI) 
was calculated.
Microarray analysis
The left testis was thawed and then total cellular RNA was extracted 
using innuPREP RNA Mini Kit  (Analytik Jena, Jena, Germany) 
according to the manufacturer’s protocol, followed by treatment 
with DNase (Thermo Scientific, Foster, CA, USA).17 The RNA quality 
and concentration were ascertained.17,18 About 200 ng of total RNA 
was used to prepare amplified cDNA with reagents provided in the 
Applause WT-Amp plus ST System Kit (Nugen Technology, San Carlos, 
CA, USA). The cDNA was purified with QIAGEN’s MinElute reaction 
Cleanup Kit (QIAGEN, Hilden, Germany) and its concentration and 
purity were determined.17 The Encore Biotin Module (Part No. 4200) 
was used to label the cDNA and then hybridized using GeneChip 
Hybridization kit  (Affymetrix Rat GeneChip St 2) for 18  h in the 
GeneChip Hybridization Oven 640  (Affymetrix, Santa Clara, CA, 
USA). Immediately following hybridization, the array was washed 
and stained with streptavidin phycoerythrin conjugate on the 
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GeneChip Fluidic Station 450 (Affymetrix, Santa Clara, CA, USA), 
followed by scanning on a GeneChip Scanner. Data from microarray 
were displayed as CEL, DAT, and JPG files. These output data from 
microarray were analyzed as gene-level differential expression 
by Affymetrix software  (Expression Console-1-3-1-64 bit and 
Transcriptome Analysis Console-2-0-64 bit). Gene expressions in 
leptin- and melatonin-treated rats that were either 2 fold greater or 
2-fold lesser than those in the control were considered significant 
(P < 0.05). Upregulated and downregulated genes were then grouped 
according to their functions using software (TIBCO® Spotfire® software 
Version  1.0.0, Palo Alto, CA, USA) Server: https://spotfire.cloud.
tibco.com/.
Real‑time PCR
Gene expressions of caspase-3  (CASP-3), apoptosis-inducing 
factor  (AIF), glutathione peroxidase 1  (GPX1), and histone 
acetyltransferases (HAT) that were found altered in the cDNA microarray 
analysis were further confirmed by real-time polymerase chain 
reaction (PCR). Briefly, total RNA was extracted from testicular tissue 
with the aid of innuPREP RNA Mini Kit (Analytik Jena, Jena, Germany) 
according to the manufacturer’s protocol. Then, 2 µl RNA  (30  ng) 
was used in a 20 µl cDNA reaction using 5x iScript™ cDNA Synthesis 
Kit  (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s 
protocol. The cDNA was further PCR-amplified by specific primers 
in 10 µl PCR mixture (SYBR Green Supermix and 25 µmol l-1 forward 
and reverse primers template) with iQ™ 5 Real-Time PCR detection 
system  (Bio-Rad, Hercules, CA, USA). The paired primer sets 
included forward CASP-3 (5’-TGAAGGGGTCATTTATGGGACA3’) 
and CASP-3 reverse  (5’-TCCCATAAATGACCCCTTCATCA3’), 
forward AIF  (5’-CCACAGCAGGAGACTGTGTGTATC3’) and 
reverse AIF   (5’-GATCCGGCGTGTACTTCCATC3’), GPX1 
for ward  (5’-GTGCAATCAGT TCGGACACCA3’)  reverse 
GPX1  (5’-GAGACGCGACAT TCTCAATGA3’)  and HAT 
forward  (5’-ACAATGTTCCGTGTTGAATATGC3’) and HAT 
r e v e r s e   ( 5 ’ - AG G TAT G A AG TA AG G T T C C G A AT G 3 ’ ) , 
Glycera ldehyde-3-Phosphate  Dehydrogenase   (GAPDH) 
forward (5’- CAACTCCCTCAAGATTGTCAGCAA3’) and GAPDH 
reverse (5’-GGCATGGACTGTGGTCATGA3’) and TATA box binding 
protein (TBP) forward (5’- TGGGATTGTACCACAGCTCCA3’), and 
TBP reverse (5’- CTCATGATGACTGCAGCAAACC3’). Normalization 
of gene expression was done with GAPDH and TBP housekeeping genes. 
The iQ™ 5 Real-Time PCR software (Bio-Rad, Hercules, CA, USA) was 
used to calculate the gene expression for all samples.
Statistical analysis
ANOVA with Tukey’s post hoc test contained in SPSS version  21 
(SPSS Inc., Chicago, Illinois, USA) was used to analyze the data. 
The data are expressed as mean ± standard deviation. A significant 
difference was accepted when P < 0.05.
RESULTS
Body weight increased in all rats over the 6-week study period 
(Table  1). However, no differences were evident in body weight 
between leptin, LM10, LM20, melatonin-only treated groups, and 
that of the control group.
Total sperm count was lower in leptin-only and LM10-treated 
rats than that in the control  (P  <  0.001 and P  <  0.01, respectively, 
Figure 1a). No difference was evident in sperm count between control 
and LM20- and M10-treated rats.
The fraction of sperm with abnormal morphology was higher in leptin 
only-treated rats compared to that in the control (P < 0.001; Figure 1b). 
No differences were evident in the fraction of sperm with abnormal 
morphology between M10, LM10, LM20, and that of saline-treated 
control group. The major morphologically abnormal sperm noticeable 
was the headless and coiled tail types.
TUNEL assay revealed evidence of higher DNA fragmentation 
and apoptosis in the seminiferous tubules of leptin-treated rats than 
that in the control rats (Figure 2). In addition, the AI in leptin-treated 
rats was higher than that in the control rats (Figure 2f). There was no 
difference in the AI between controls and rats given melatonin at a 
dose of 20 mg kg−1 body weight.
No difference was evident in the level of sperm 8-OHdG between 
control and LM20-  and M10-treated rats. However, 8-OHdG 
level was higher in leptin-only and LM10-treated rats than that in 
controls (P < 0.001 and P < 0.05, respectively, Figure 3).
Tail length, tail moment, olive tail moment, and % tail DNA were 
higher in leptin-only, LM10-, and LM20-treated rats than that in the 
controls (Table 2). These four parameters were higher in leptin- and 
LM10-treated rats than that in the LM20-treated rats.
Microarray analysis revealed 1893 and 1119 genes that were 
upregulated in leptin-treated rats and LM20-treated rats, respectively. 
A  total of 3800 and 898 genes were downregulated in leptin-  and 
LM20-treated rats, respectively, when compared with the expressions 
in the controls. Of these, some of the genes regulating apoptosis, 
DNA damage, DNA repair, cell necrosis, antioxidant enzymes, and 
respiratory chain reaction enzymes are shown in Table 3.
Real-time PCR revealed a higher mRNA expression of AIF in 
the testes of leptin-treated rats than that in LM20-treated and control 
Table 1: Body weight in control and leptin‑treated rats
Groups Body weight (g) ± s.d.
Day 0 Day 42
Control 345.83±11.13 412.67±15.81***
Leptin 344.33±12.26 411.00±12.60***
Leptin‑melatonin 10 345.52±5.43 410.00±15.59***
Leptin‑melatonin 20 339.00±5.85 403.67±2.19***
Melatonin 10 342.00±3.98 413.33±9.73***
Data are presented as mean±s.d. ***P<0.001, Day 42 versus Day 0. s.d.: standard deviation
Table 2: Sperm with ssDNA break in rat of experimental groups shown 
by Comet assay (mean±s.d.)




Olive tail moment 
(arbitrary unit)
% tail DNA 
(arbitrary unit)
Control 19.25±4.93 2.09±0.88 2.25±0.37 0.88±0.09
Leptin 39.87±2.41*** 7.19±1.00*** 6.56±0.81*** 1.61±0.25***
LM‑10 34.06±3.53** 6.08±0.26** 5.36±0.84** 1.24±0.18**
LM‑20 22.75±2.62 3.09±0.59* 3.09±0.13* 1.07±0.05*
M‑10 20.89±1.69 3.04±0.68 2.84±0.33 0.95±0.01
*P<0.05; **P<0.01; ***P<0.001. Leptin, LM10, LM20 and M10 versus Control. LM10: leptin‑ 
melatonin‑10; LM20: leptin‑melatonin‑20; M10: melatonin‑10; s.d.: standard deviation
Figure 1: Sperm count (a) and sperm morphology (b) in leptin‑ and 
melatonin‑treated rats compared to control. **P < 0.01; ***P < 0.001.
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rats  (P  <  0.01; Figure  4a). No difference was evident in CASP-3 
mRNA expression between leptin-treated, LM20-treated, and control 
rats  (Figure  4b). The mRNA expression of GPX1 was lower in 
leptin-treated rats than those in LM20-treated and control rats (P < 0.01; 
Figure  4c). The HAT mRNA expression was higher in leptin-  and 
LM20-treated rats than that in control rats (P < 0.01; Figure 4d).
DISCUSSION
The major findings of this study include: (a) lower total sperm count 
in leptin-treated rats when compared with that in saline-treated 
controls,  (b) higher fraction of sperm with abnormal morphology 
in leptin-treated rats,  (c) higher apoptotic activity and DNA 
fragmentation in leptin-treated rats, (d) higher levels of 8-OHdG in 
leptin-treated rats,  (e) differential expression of a number of genes 
following leptin and melatonin treatment, and  (f) no significant 
differences in sperm count, abnormal sperm morphology, apoptotic 
activity, DNA fragmentation, and 8-OHdG levels between controls 
and leptin + melatonin-treated rats.
The precise mechanism for the lower total sperm count and 
higher fraction of sperm with abnormal morphology following leptin 
treatment is still unclear. Decreases in sperm count and increased 
fraction of sperm with abnormal morphology following leptin 
treatment have been reported before.5,6,8 Increased sperm 8-OHdG, a 
marker of DNA damage due to oxidative stress in rats, and increased 
intracellular levels of reactive oxygen species (ROS) following leptin 
treatment have been reported recently.7,8  The main sources of ROS 
are seminal leukocytes and spermatozoa, and low levels of ROS 
are necessary for normal sperm functions including capacitation, 
hyperactivation, and acrosome reaction. However, when produced in 
large amounts, it is detrimental to sperm and germinal cells. Leptin 
has also been shown to increase superoxide anion production (O2•−) 
in vascular smooth muscle cells in culture9 and in aortic endothelial 
cells via protein kinase-A-mediated fatty acid oxidation.19 It also causes 
peroxynitrite-mediated oxidative stress in steatohepatic lesions.20 
Leptin-induced ROS production in mouse hepatocytes is inhibited 
by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, 
MAP kinase/ERK kinase 1  (MEK1), and Janus kinase 2  (JAK2) 
inhibitors, suggesting the possible involvement of these pathways in 
leptin-induced ROS production.21
The expression of HAT and histone deacetylase  (HDAC) was 
significantly higher in leptin-treated rats than that in control and 
LM20-treated rats. Leptin has been shown to increase the involvement 
of histone acetyl transferases in growth-stimulating activity of 
breast cancer cells.22 Histone acetylation plays an important role in 
spermatogenesis.23 Histone acetylation of lysine residues, clustered 
at the amino-terminal end of core histones, is regulated by HAT that 
facilitate acetylation, and HDAC that decrease acetylation.23,24 A recent 
study demonstrated a significant positive relationship between HAT 
activity and sperm DNA fragmentation index.23 When histones are 
acetylated, their affinity to DNA is decreased by the loss of the positive 
charge. This then loosens the DNA chromatin structure or makes it 
less compact for active transcription.25 However, if histones bound to 
DNA are hyperacetylated, the DNA chromatin becomes further less 
compact and becomes more susceptible to fragmentation.
The impact of leptin on DNA damage possibly occurs through 
leptin-induced increase in production of ROS. In this regard, 
microarray analysis results revealed a significant upregulation of the 
electron transfer chain enzymes in mitochondria and downregulation 
of the expression of antioxidant enzymes, catalase (CAT), glutathione 
peroxidase 1  (GPX1), peroxiredoxin 1  (Prdx1), and glutathione 
S-transferase pi 1  (Gstp1) following leptin treatment. This might 
result in increased production of ROS and oxidative stress, as has 
been reported recently following leptin treatment.8 The upregulation 
of HAT gene at the same time might make the DNA less compact and 
more susceptible to ROS attack, and thereby leading to an increase in 
DNA fragmentation.
Microarray analysis of the DNA damage genes also revealed an 
upregulation in the expression of ataxia telangiectasia mutated (ATM), 
ATM and DNA repair protein rad3-related  (ATR), and TP53 and 
p21 genes in leptin-treated rats. It has been reported that the early 
molecules that respond to DNA damage consist of ATM and ATR 
genes.26 The ATM and ATR proteins belong to the phosphatidylinositol 
3-kinase-like (PIKK) family of serine/threonine protein kinases and 
these phosphorylate the DNA damage mediator protein TP53. The 
target of the transcription factor TP53 is p21, which, in turn, inhibits 
cyclin-dependent kinase 1 (CDK1) activity, causing arrest of the cell 
cycle. When the cell cycle arrests, the DNA repair machinery becomes 
effective.26 If the DNA repair is successful, the cell cycle arrest is 
lifted, but if the repair is unsuccessful, then programed cell death 
Figure 2: Results of TUNEL assay in control (a), leptin‑treated (b), 
leptin‑melatonin‑10 (LM10) treated (c), leptin‑melatonin‑20 (LM20) 
treated (d), melatonin‑10 (M10) treated (e) rats, and apoptosis index (f). 






Figure 3: Sperm 8‑hydroxy‑2‑deoxyguanosine (8‑OHdG) levels in control, 
leptin, leptin‑melatonin‑10 (LM10), leptin‑melatonin‑20 (LM20), and 
melatonin‑10 (M10) rats. *P < 0.05; ***P < 0.001.
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follows. DNA repair genes, polymerase beta (POLB), ligase III, (Lig3), 
X-ray repair complementing defective repair  (Xrcc1), and poly  (A) 
polymerase alpha (Papola) were significantly upregulated following 
leptin treatment. The increased cell death, as evident from the TUNEL 
assay, despite the increased expression of DNA repair genes, suggests 
that the repair was inadequate to sustain the cell cycle in leptin-treated 
rats. TUNEL assay and Comet assay revealed higher apoptotic activity 
and DNA fragmentation in rats treated with leptin alone than that 
in the control and melatonin-treated rats, particularly at a dose of 
20 mg kg−1 body weight.
To understand the mechanism of leptin-induced apoptosis, 
the expression of caspase-dependent and caspase-independent cell 
death-related genes in the testis was determined. Of the genes involved in 
caspase-dependent apoptosis, caspase-3, caspase-8, and caspase-9 were 
Table 3: Detailed gene profile analysis by microarray analysis
Gene symbol Gene description Leptin versus control Leptin‑melatonin‑20 
versus control
Fold change Status Fold change Status
Antioxidant enzymes
Cat Catalase −1.2 Downregulated ‑ Unchanged
Prdx1 Peroxiredoxin 1 −1.62 Downregulated ‑ Unchanged
Gpx7 Glutathione peroxidase 7 −1.27 Downregulated ‑ Unchanged
Gpx1 Glutathione peroxidase 1 −1.28 Downregulated ‑ Unchanged
Gstp1 Glutathione S‑transferase pi 1 −1.3 Downregulated ‑ Unchanged
Gstt4 Glutathione S‑transferase, theta 4 10.5 Upregulated ‑ Unchanged
Sod1 Superoxide dismutase 1, soluble 4.37 Upregulated 1.97 Upregulated
Respiratory chain reaction enzymes
Ndufaf3 NADH dehydrogenase (ubiquinone) complex I, assembly 
factor 3
3.68 Upregulated ‑ Unchanged
Sdh Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) 1.91 Upregulated ‑ Unchanged
Uqcrfs1 Ubiquinol‑cytochrome c reductase, Rieske iron‑sulfur 
polypeptide 1
1.87 Upregulated ‑ Unchanged
Coa3 Cytochrome C oxidase assembly factor 3 4.42 Upregulated ‑ Unchanged
DNA damage
ATM Ataxia telangiectasia mutated 1.12 Upregulated ‑ Unchanged
ATR ATM‑ and rad3‑related 2.22 Upregulated ‑ Unchanged
TP53 Tumor protein p53 1.19 Upregulated ‑ Unchanged
p21 Protein p21 2.98 Upregulated 1.96 Upregulated
Cdk1 Cyclin‑dependent kinase 1 ‑ Unchanged ‑ Unchanged
DNA repair
POLB Polymerase (DNA directed), beta 4.08 Upregulated 2.14 Upregulated
Lig3 Ligase III, DNA, ATP‑dependent 4.98 Upregulated ‑ Unchanged
Xrcc1 X‑ray repair complementing defective repair in Chinese 
hamster cells 1
1.33 Upregulated ‑ Unchanged
Papola Poly (A) polymerase alpha 3.54 Upregulated ‑ Unchanged
Pcna Proliferating cell nuclear antigen 4.55 Upregulated ‑ Unchanged
XPC Xeroderma pigmentosum, complementation group C 1.34 Upregulated ‑ Unchanged
Cell necrosis
PARP1 Poly(ADP‑ribose) polymerase 1 2.16 Upregulated ‑ Unchanged
RIPK1 RIP1 Receptor (TNFRSF)‑interacting serine‑threonine kinase 1 1.14 Upregulated ‑ Unchanged
TNF Tumor necrosis factor, alpha 8.55 Upregulated ‑ Unchanged
JNK c‑Jun N‑terminal kinase 1.99 Upregulated ‑ Unchanged
TRAF2 TNF receptor associated factor 2 1.66 Upregulated ‑ Unchanged
Apoptosis
Casp3 Caspase‑3 ‑ Unchanged ‑ Unchanged
Casp8 Caspase‑8 ‑ Unchanged ‑ Unchanged
Casp9 Caspase‑9 ‑ Unchanged ‑ Unchanged
Bcl2 Bcl2‑like‑1 −2.22 Downregulated −2.87 Downregulated
AIF Apoptosis‑inducing factor 1.44 Upregulated ‑ Unchanged
Ctsd Cathepsin D 1.49 Upregulated ‑ Unchanged
HTRA2 High temperature requirement protein A2 1.11 Upregulated ‑ Unchanged
Genes involved in spermatogenesis
HAT Histone acetyltransferase 2.17 Upregulated ‑ Unchanged
HDAC1 Histone deacetylase1 4.3 Upregulated ‑ Unchanged
HDAC2 Histone deacetylase2 4.07 Upregulated ‑ Unchanged
Rad3: DNA repair protein rad3; ATP: adenosine triphosphate; ADP: adenosine diphosphate; TNFRSF: tumor necrosis factor receptor superfamily
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not different between control and leptin-treated rats. Interestingly, the 
expression of AIF, high temperature requirement protein A2 (HTRA2), 
and cathepsin D (Ctsd) genes involved in caspase-independent cell death 
showed a significant upregulation, suggesting that leptin-induced cell 
death via a caspase-independent pathway. Pro-survival and pro-death 
signals are generated in response to multiple intracellular stress 
conditions and these signals converge to a mitochondrion-centered 
control mechanism. When lethal signals prevail, mitochondrial outer 
membrane permeabilization (MOMP) occurs and leads to mitochondrial 
trans-membrane potential dissipation,27 leading to ROS overgeneration 
and release of proteins into the cytosol that are normally confined 
within the mitochondrial intermembrane space (IMS). These proteins 
include apoptosis-inducing factor and HTRA2. Apoptosis-inducing 
factor is a mitochondrial protein that plays a pivotal role in programmed 
cell death. Apoptosis-inducing factor becomes an active cell killer 
when it is released from mitochondria to the cytosol, from where it 
then translocates to the nucleus and triggers peripheral chromatin 
condensation and DNA fragmentation and DNA loss.28,29 In addition, 
the serine protease HTRA2 also contributes to caspase-independent 
apoptosis by cleaving a wide array of cellular substrates including 
cytoskeletal proteins.30 The lysosomal protease cathepsin D has been 
reported to trigger apoptosis-inducing factor release independent of the 
caspase cascade.29,30 In addition, the death cell receptors including tumor 
necrosis factor (TNF) have been reported to induce a necrotic-like cell 
death when caspases are inhibited and this type of cell death is mediated 
by ROS generation.31 Tumor necrosis factor initiates necrosis of the cell 
through sustained activation of c-Jun N-terminal kinase (JNK), which 
is mediated by the central initiator of necrosis receptor (tumor necrosis 
factor receptor superfamily)-interacting serine-threonine kinase 
1  (RIP1) and TNF receptor-associated factor 2  (TRAF2). Activated 
c-Jun N-terminal kinase impairs mitochondrial membrane integrity 
causing release of mitochondrial inter-membrane space proteins and 
consequent necrosis.32 Our results show that TNF, RIP1, TARF2, and 
JNK genes are significantly upregulated in leptin-treated rat testes. This 
finding suggests that leptin induced a necrotic-like cell death through 
the activation of TNF and JNK pathways.
Concurrent daily administration of melatonin prevented the 
adverse effects of leptin, particularly when given at a dose of 
20  mg kg−1 body weight per day. Melatonin has been reported to 
prevent gentamycin-induced testicular toxicity in rats.33 In addition, it 
has also been shown to have potent protective effects against anticancer 
drug-induced testicular toxicity, including reduced sperm count and 
lowered sperm motility.34,35 Recent studies have also demonstrated that 
melatonin prevents oxidative damage and testicular toxicity induced by 
ochratoxin A, cyclophosphamide, electromagnetic radiation, testicular 
ischemia–reperfusion, and hypoxia, and it also supports the antioxidant 
redox system in the testis.36–40 More interestingly, leptin-induced 
increases in O2•− in primary cultured vascular smooth muscle cells 
were prevented by melatonin.9 It is, therefore, possible that melatonin 
reduced the adverse effects of leptin by reducing the level of oxidative 
stress. Besides functioning as a synchronizer of the biological clock, 
melatonin is a powerful antioxidant,41 particularly protecting nuclear and 
mitochondrial DNA.42 It scavenges hydroxyl radical (OH•), peroxynitrite 
anion (ONOO−), O2•−, nitric oxide radical (NO•), and peroxy radicals.43 
It is also known to enhance the antioxidant activities of superoxide 
dismutase (SOD), glutathione peroxidase (GPx), catalase, and glutathione 
reductase (GR).44–46 Besides this, melatonin has been shown to increase 
GPx protein in the kidney of spontaneously hypertensive rats (SHR),47 
and increase GPx-1 mRNA expression in human chorion, rat liver, and 
rat brain cortex.48–50 Moreover, it also enhances the ability of cells to resist 
oxidative damage by inhibiting the pro-oxidant nitric oxide synthase.51 
Reproductive systems of different species have binding sites for melatonin, 
so it seems reasonable to assume that melatonin also exerts its actions 
through direct interaction with the cells of the reproductive organs.52,53
CONCLUSION
It appears that leptin administration increases the levels of oxidative 
stress in the testes causing necrotic-like cell death through TNF and 
JNK pathways. Melatonin prevents these leptin-induced adverse 
effects on sperm count, sperm morphology, DNA fragmentation, 
and apoptosis, which might be due to its antioxidant activity. These 
findings suggest that melatonin might be a useful protective agent 
Figure 4: Relative fold expression (RFE) mRNA of AIF (a), CASP‑3 (b), GPX1 (c), and HAT (d) in control, leptin‑treated, and leptin‑melatonin‑20 treated (LM20) 
rats. *P < 0.05, **P < 0.01, leptin versus control; ##P < 0.01, ###P < 0.001, leptin versus LM20.
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against leptin-induced damage to the male reproductive organs 
and infertility.
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